IAM
ANGO icon

Iridian Asset Management’s AngioDynamics ANGO Stock Holding History

Iridian Asset Management’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-16,210
Closed -$222K – 80
2014
Q3 		$222K Buy
16,210
+6,060
+60% +$86.5K ﹤0.01% 74
2014
Q2 		$166K Sell
10,150
-5,960
-37% -$86.3K ﹤0.01% 104
2014
Q1 		$254K Sell
16,110
-12,910
-44% -$210K ﹤0.01% 107
2013
Q4 		$498K Sell
29,020
-6,340
-18% -$97.6K 0.01% 66
2013
Q3 		$467K Sell
35,360
-230
-0.6% -$2.71K 0.01% 61
2013
Q2 		$401K Buy
+35,590
New +$379K 0.01% 66

Other funds holding ANGO

ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LAM
Lapides Asset Management Greenwich, Connecticut $153M AUM 9.03% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Iridian Asset Management's ANGO Position: Q4 2014 in Review

Iridian Asset Management sold out of AngioDynamics (ANGO) in Q4 2014, closing a stake of 16,210 shares — an estimated $222K sold.

Iridian Asset Management first reported a position in ANGO in Q2 2013 and held it in 6 quarters. The position peaked at $498K in Q4 2013. 132 funds tracked by Wall St. Rank hold ANGO as of Q4 2014.

  • Iridian Asset Management reported no remaining AngioDynamics position as of Q4 2014 after selling out during the quarter.
  • Iridian Asset Management sold 16,210 AngioDynamics shares in Q4 2014, an estimated $222K.
  • Iridian Asset Management first reported a position in AngioDynamics in Q2 2013 and held it in 6 quarters.
  • Iridian Asset Management's AngioDynamics position peaked at $498K in Q4 2013.
  • 132 funds tracked by Wall St. Rank held AngioDynamics as of Q4 2014.

Based on Iridian Asset Management's 13F filing for Q4 2014, filed 10 Feb 2015.